Indian Society of Critical Care Medicine
Mumbai, India
NCT Number: NCT01346735
Most literature on ICU infections and the resistant patterns comes from the western literature. This data may not truly reflect the incidence, epidemiology and resistance patterns in developing countries such as India. However, empiric antibiotic therapy is generally initiated using western guidelines. This can potentially lead to inadequate, inappropriate and ineffective empiric antibiotic therapy for ICU infections in the Indian setting. Hence in this multi-center observational study, we seek to:
1. To determine the incidence of ICU-related infections (VAP, CAUTI and CRBSI) in India 2. To explore the microbiology, resistance and treatment patterns of these infections
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Mumbai, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Indian Society of Critical Care Medicine
Other
Acronym: MOSER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02756351
Cross Infection, Disease Attributes
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT01338116
Community-associated Infections, Cross Infection
Petah Tikvah, Israel
View Trial DetailsNCT04748432
Cross Infection, Disease Attributes
Konya, Turkey (Türkiye)
View Trial DetailsNCT02600195
Cross Infection, Disease Attributes
Hefei, Anhui, China
View Trial Details